Searchable abstracts of presentations at key conferences in endocrinology

ea0034p123 | Clinical practice/governance and case reports | SFEBES2014

Hypomagnesaemia during proton pump inhibitor therapy causing functional hypoparathyroidism

Krishnasamy Senthilkumar , Abbott Vineet , Kannan Rajendran Bellan , Varughese George , Nayak Ananth , Varadhan Laks , Jose Biju

Proton pump inhibitors (PPI) are widely prescribed. PPI-induced diarrhoea and hypomagnesaemia are well-documented in literature. Hypomagnesaemia is well-known to cause functional hypoparathyroidism. We describe a patient who had transient profound hypoparathyroidism which improved on discontinuing PPI and normalising severe hypomagnesaemia.A 72-year-old male, who was on oral anti-diabetic medications, calcium/vitamin D3 supplements and PPI, presented wit...